<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>
	<title>CLINHOPE CONSULTING CO., LTD</title>
	<language>en_US</language>
	<generator>PRN Asia</generator>
	<description><![CDATA[we tell your story to the world!]]></description>
		<item>
		<title>ClinHope Officially Establishes Hong Kong Branch to Strengthen Asia-Pacific Market Presence</title>
		<author></author>
		<pubDate>2026-09-03 16:09:00</pubDate>
		<description><![CDATA[TAIPEI, Sept. 3, 2026 /PRNewswire/ -- ClinHope today announced the official 
establishment of its Hong Kong branch. Following its operations in Taiwan and 
the United States, this marks another step in expanding into the Asian market 
and deepening its global service footprint.

As the biotech, pharmaceutical, and medical device industries continue to 
move toward international development, ClinHope is committed to supporting 
clients with professional services in clinical research, regulatory affairs, 
and quality management to meet diverse market needs.

Hong Kong's highly internationalized environment and strategic role in 
connecting Asia with global markets make it an ideal hub. ClinHope will 
leverage Hong Kong as a key Asia-Pacific base to expand regional markets and 
international cooperation, while integrating resources from Taiwan, the United 
States, and Hong Kong to deliver more comprehensive cross-regional services.

ClinHope CEO, Ms. Abby Chang, stated that the establishment of the Hong Kong 
branch is an important milestone in the company's globalization journey. Moving 
forward, ClinHope will continue to expand its Asia-Pacific and global 
collaboration networks, combining local expertise with international vision to 
provide professional services in clinical research, regulatory affairs, quality 
management, and related fields for the biotech, pharmaceutical, and medical 
device industries.

ClinHope will remain dedicated to connecting Asian and global markets, 
working with clients and partners to create new opportunities for international 
growth.

About ClinHope

ClinHope specializes in providing professional services in clinical research, 
pharmaceuticals, and healthcare. Its service scope includes clinical trials, 
regulatory affairs, quality management, and related projects and consulting. 
The company is dedicated to helping biotech, pharmaceutical, and medical device 
clients meet diverse professional and regulatory requirements across different 
markets.

Currently, ClinHope has established operations in Taiwan, the United States, 
and Hong Kong, and continues to expand its global collaboration network. By 
integrating cross-regional teams, expertise, and local market experience, 
ClinHope strives to be a trusted international partner for its clients.

ClinHope Team
info@clinhope.com <mailto:info@clinhope.com> 
+886-2-28353685

]]></description>
		<detail><![CDATA[<table name="logo_release" border="0" cellspacing="10" cellpadding="5" align="right"> 
 <tbody> 
  <tr> 
   <td><img src="https://mmx.prnasia.com/media/MS1981076/20260903023746EDT_image_1.jpg?id=OA2928044&amp;p=medium600" border="0" alt="" title="logo" hspace="0" vspace="0" width="118" /></td> 
  </tr> 
 </tbody> 
</table> 
<p><span class="legendSpanClass">TAIPEI</span>, <span class="legendSpanClass">Sept. 3, 2026</span> /PRNewswire/ -- ClinHope today announced the official establishment of its Hong Kong branch. Following its operations in Taiwan and the United States, this marks another step in expanding into the Asian market and deepening its global service footprint.</p> 
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> 
</div> 
<p>As the biotech, pharmaceutical, and medical device industries continue to move toward international development, ClinHope is committed to supporting clients with professional services in clinical research, regulatory affairs, and quality management to meet diverse market needs.</p> 
<p>Hong Kong's highly internationalized environment and strategic role in connecting Asia with global markets make it an ideal hub. ClinHope will leverage Hong Kong as a key Asia-Pacific base to expand regional markets and international cooperation, while integrating resources from Taiwan, the United States, and Hong Kong to deliver more comprehensive cross-regional services.</p> 
<p>ClinHope CEO, Ms. Abby Chang, stated that the establishment of the Hong Kong branch is an important milestone in the company's globalization journey. Moving forward, ClinHope will continue to expand its Asia-Pacific and global collaboration networks, combining local expertise with international vision to provide professional services in clinical research, regulatory affairs, quality management, and related fields for the biotech, pharmaceutical, and medical device industries.</p> 
<p>ClinHope will remain dedicated to connecting Asian and global markets, working with clients and partners to create new opportunities for international growth.</p> 
<p><b>About ClinHope</b></p> 
<p>ClinHope specializes in providing professional services in clinical research, pharmaceuticals, and healthcare. Its service scope includes clinical trials, regulatory affairs, quality management, and related projects and consulting. The company is dedicated to helping biotech, pharmaceutical, and medical device clients meet diverse professional and regulatory requirements across different markets.</p> 
<p>Currently, ClinHope has established operations in Taiwan, the United States, and Hong Kong, and continues to expand its global collaboration network. By integrating cross-regional teams, expertise, and local market experience, ClinHope strives to be a trusted international partner for its clients.</p> 
<p>ClinHope Team<br /><a href="mailto:info@clinhope.com" target="_blank" rel="nofollow" style="color: #0000FF">info@clinhope.com</a>&nbsp;<br />+886-2-28353685</p>]]></detail>
		<source><![CDATA[ClinHope]]></source>
	</item>
	
</channel>
</rss>